ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study of PAL A (NSC 224131) in patients with advanced ovarian carcinoma A Gynecologic Oncology Group study
American Journal of Clinical Oncology
◽
10.1097/00000421-198406000-00011
◽
1984
◽
Vol 7
(3)
◽
pp. 257-260
◽
Cited By ~ 3
Author(s):
Hyman B. Muss
◽
Milan Slavik
◽
Brian Bundy
◽
Frederick B. Stehman
◽
William T. Creasman
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Advanced Ovarian Carcinoma
Download Full-text
Related Documents
Cited By
References
Aminothiadiazole (NSC 4728) in Patients with Advanced Ovarian Carcinoma A Phase II Study of the Gynecologic Oncology Group
American Journal of Clinical Oncology
◽
10.1097/00000421-198608000-00012
◽
1986
◽
Vol 9
(4)
◽
pp. 334-336
◽
Cited By ~ 4
Author(s):
Robert F. Asbury
◽
James Wilson
◽
John A. Blessing
◽
Herbert J. Buchsbaum
◽
Philip J. DiSaia
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Advanced Ovarian Carcinoma
Download Full-text
A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.1998.5206
◽
1998
◽
Vol 71
(3)
◽
pp. 410-415
◽
Cited By ~ 17
Author(s):
Lynn G. Feun
◽
John A. Blessing
◽
Francis J. Major
◽
Philip J. DiSaia
◽
Ronald D. Alvarez
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase II Study of Ifosfamide and Mesna in Nonsquamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.1993.1084
◽
1993
◽
Vol 49
(1)
◽
pp. 48-50
◽
Cited By ~ 25
Author(s):
Gregory P. Sutton
◽
John A. Blessing
◽
Philip J. DiSaia
◽
William P. McGuire
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2006.03.043
◽
2006
◽
Vol 103
(2)
◽
pp. 523-526
◽
Cited By ~ 30
Author(s):
Paula M. Fracasso
◽
John A. Blessing
◽
Kelly L. Molpus
◽
Lisa M. Adler
◽
Joel I. Sorosky
◽
...
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Second Line
◽
Oncology Group
◽
Oncology Group Study
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.05.029
◽
2018
◽
Vol 150
(2)
◽
pp. 247-252
◽
Cited By ~ 18
Author(s):
John K. Chan
◽
William Brady
◽
Bradley J. Monk
◽
Jubilee Brown
◽
Mark S. Shahin
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Clear Cell
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Clear Cell Ovarian Carcinoma
Download Full-text
Phase II study of esorubicin (4?-deozydoxorubicin) in advanced epithelial carcinoma of the ovary: A Gynecologic Oncology Group study
Investigational New Drugs
◽
10.1007/bf00173763
◽
1989
◽
Vol 7
(4)
◽
Cited By ~ 1
Author(s):
WilliamP. McGuire
◽
JohnA. Blessing
◽
MichaelL. Berman
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Carcinoma Of The Ovary
Download Full-text
2A phase II study to determine the response to second curettage as initial management for persistent “low-risk” non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2014.07.079
◽
2014
◽
Vol 134
(2)
◽
pp. 438-439
◽
Cited By ~ 1
Author(s):
R.J. Osborne
◽
V.L. Filiaci
◽
R.S. Mannel
◽
S.A. Davidson
◽
J.S. Hoffman
◽
...
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Low Risk
◽
Gynecologic Oncology Group
◽
Gestational Trophoblastic Neoplasia
◽
Oncology Group
◽
Initial Management
◽
Oncology Group Study
Download Full-text
A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.2000.6024
◽
2001
◽
Vol 81
(2)
◽
pp. 213-215
◽
Cited By ~ 78
Author(s):
Laila I. Muderspach
◽
John A. Blessing
◽
Charles Levenback
◽
James L. Moore
Keyword(s):
Squamous Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Squamous Cell
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary A Gynecologic Oncology Group Study
American Journal of Clinical Oncology
◽
10.1097/00000421-198306000-00003
◽
1983
◽
Vol 6
(3)
◽
pp. 273-276
◽
Cited By ~ 16
Author(s):
J. Tate Thigpen
◽
Clarence E. Ehrlich
◽
William T. Creasman
◽
Stephen Curry
◽
John A. Blessing
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Adenocarcinoma Of The Ovary
Download Full-text
Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.1999.5532
◽
1999
◽
Vol 75
(1)
◽
pp. 10-14
◽
Cited By ~ 48
Author(s):
Jonathan S. Berek
◽
Maurie Markman
◽
Bette Stonebraker
◽
Samuel S. Lentz
◽
Mark D. Adelson
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Gynecologic Oncology
◽
Interferon Α
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close